Sino Medical Sciences Technology In (688108) — Cash Flow-to-Debt Ratio
Sino Medical Sciences Technology In (688108) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥31.52 Million could theoretically repay 0% of its total liabilities (CN¥407.00 Million) in one year. See financial flexibility index of Sino Medical Sciences Technology In to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sino Medical Sciences Technology In Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Sino Medical Sciences Technology In across 9 annual periods. For the full cash flow conversion analysis, see 688108 operating cash flow.
Annual Cash Flow-to-Debt Ratio for Sino Medical Sciences Technology In (2016–2024)
Year-by-year debt coverage analysis for Sino Medical Sciences Technology In. Check Sino Medical Sciences Technology In earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.33x | CN¥131.24 Million | CN¥402.22 Million | ▲ +86.1% |
| 2023 | 0.18x | CN¥56.84 Million | CN¥324.17 Million | ▲ +128.4% |
| 2022 | -0.62x | CN¥-111.31 Million | CN¥180.13 Million | ▼ -62.3% |
| 2021 | -0.38x | CN¥-60.13 Million | CN¥157.92 Million | ▼ -175.4% |
| 2020 | 0.50x | CN¥70.51 Million | CN¥139.63 Million | ▼ -60.7% |
| 2019 | 1.28x | CN¥137.61 Million | CN¥107.11 Million | ▲ +38.0% |
| 2018 | 0.93x | CN¥97.56 Million | CN¥104.83 Million | ▲ +37.1% |
| 2017 | 0.68x | CN¥70.32 Million | CN¥103.62 Million | ▲ +25.4% |
| 2016 | 0.54x | CN¥42.24 Million | CN¥78.06 Million | — |